BioAffinity Historical Cash Flow
| BIAFW Stock | USD 0.72 0.03 4.00% |
Analysis of BioAffinity Technologies cash flow over time is an excellent tool to project BioAffinity Technologies future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Begin Period Cash Flow of 12 M or Depreciation of 262.1 K as it is a great indicator of BioAffinity Technologies ability to facilitate future growth, repay debt on time or pay out dividends.
BioAffinity |
About BioAffinity Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in BioAffinity balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which BioAffinity's non-liquid assets can be easily converted into cash.
BioAffinity Technologies Cash Flow Chart
Add Fundamental
Free Cash Flow
The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.Change In Working Capital
The difference in the amount of working capital from one period to the next, indicating the change in a company's short-term assets and liabilities.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Most accounts from BioAffinity Technologies' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into BioAffinity Technologies current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in bioAffinity Technologies Warrant. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. At this time, BioAffinity Technologies' Begin Period Cash Flow is fairly stable compared to the past year. Depreciation is likely to climb to about 262.1 K in 2024, despite the fact that Free Cash Flow is likely to grow to (5.8 M).
BioAffinity Technologies cash flow statement Correlations
Click cells to compare fundamentals
BioAffinity Technologies Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for BioAffinity Stock Analysis
When running BioAffinity Technologies' price analysis, check to measure BioAffinity Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioAffinity Technologies is operating at the current time. Most of BioAffinity Technologies' value examination focuses on studying past and present price action to predict the probability of BioAffinity Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioAffinity Technologies' price. Additionally, you may evaluate how the addition of BioAffinity Technologies to your portfolios can decrease your overall portfolio volatility.